GSK Blasts Appeal Bid In Pa. Paxil Venue Dispute

Law360, New York (January 8, 2014, 8:12 PM EST) -- GlaxoSmithKline LLC on Monday blasted a bid to have the Third Circuit decide whether the company could send a suit alleging antidepressant drug Paxil caused birth defects from state to federal court more than a year after the suit began.

GSK challenged the plaintiffs' Dec. 23 petition for permission to appeal the company's removal of the case to federal court following a landmark Third Circuit ruling in June keeping a separate suit over GSK’s morning-sickness drug thalidomide in federal court, saying there were no exceptional circumstances...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.